about
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesPlatelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study.Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells.Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.Hypertension and aortorenal disease in Alagille syndrome.Pharmacology and mechanisms of action of new oral anticoagulants.Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study.Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure.Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.Modeling for critically ill patients: An introduction for beginners.Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiograGENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, "GENEREPOL study": Lack of common variants with large effect sizes.Sickle-cell and alpha-thalassemia traits resulting in non-atherosclerotic myocardial infarction: Beyond coincidence?Complex Association of Sex Hormones on Left Ventricular Systolic Function: Insight into Sexual Dimorphism.Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes.Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study.Clinical pharmacology of anti-angiogenic drugs in oncology.Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration.Pharmacologic Venous Thromboprophylaxis After Bariatric Surgery: Burning Questions Regarding Doses, Duration, and Strategy.Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.Lean body weight is the best scale for venous thromboprophylaxis algorithm in severely obese patients undergoing bariatric surgery.Fast, accurate and easy-to-teach QT interval assessment: The triplicate concatenation method.Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms.Heart failure with preserved ejection fraction as an independent risk factor of mortality after cardiothoracic surgery.Influence of steroid hormones on ventricular repolarization.Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocolFatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisEffect of recipient gender and donor specific antibodies on antibody-mediated rejection after heart transplantationIncreased Reporting of Immune Checkpoint Inhibitor-Associated DiabetesEffectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodaroneInterindividual variability in dabigatran and rivaroxaban exposure: contribution ofABCB1genetic polymorphisms and interaction with clarithromycinAssociation of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal WomenImmune Checkpoint Inhibitor-Associated MyositisImpact of Inodilator Drugs on Echocardiographic Assessments of Left Ventricular Filling Pressure in Patients With Decompensated End-Stage Heart Failure*Early central blood pressure elevation in adult patients with 21-hydroxylase deficiencyNeurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance studyTransfemoral aortic valve implantation in a renal transplant patient with a Dacron aorto-bi-iliac bypass
P50
Q26865173-7CBB384E-8A10-4141-A403-2375225F0211Q36244001-25D16CD1-B795-449E-936B-DA647F22A254Q37613893-4B67956E-CA9E-426D-9439-36AE0BE3FCCEQ37644184-B2D56964-3AE9-49F0-84F4-FC5ACA77D1F0Q38004665-2F5E0DF8-982E-49B4-8617-732FE61F519AQ38246726-F3F5000B-1FAB-40C7-975B-114D828E0CECQ38403462-CBCC6860-8B11-4F36-9E90-EEC0A91AEAE9Q38541742-792F9A6B-0123-4A4A-8C9D-2D0518DD0285Q38607586-24A3B355-4B94-4BF6-9859-BD6D748B1EB6Q38844989-DADAC552-E5F3-4859-BBC0-F9A9880DD045Q40849842-ABD3807F-9651-4654-A647-54A7150234DCQ41088603-600E34BB-635F-4E97-AC95-691C911BF308Q41362902-E8C325FA-E5E3-4504-88CA-D28AE840A215Q47103213-EFC9B23F-39AD-42CD-AF50-CBE7EC0DABD5Q47300910-5BEA99D2-DEC8-4FE5-AB31-208D174DF459Q47582251-C1D5A5E0-702D-4AC9-9F14-645690378564Q47630132-222C9833-7719-44AD-9CA9-3D4A8FB529ECQ47643619-BC2504A9-DFEF-4E53-A513-1AF2C4C163C0Q47794229-4ECFB43F-689F-44E9-BCF7-B2AA85F3C21AQ48534973-EFA94073-C326-47AD-9C92-FBF0F0491421Q48653311-11367032-ECB4-47AE-85F4-4A0AA667374AQ48761160-327075ED-7995-4D97-8C01-D37FE657E8C9Q49922918-B182E348-8930-405B-A604-94B4866AB808Q50438179-C4A987D7-B0EE-49BD-B914-25522C490AC0Q52308754-0BEC707C-CC5F-41EA-9425-A366ACE30231Q52659908-7DBDD8CF-AB40-49E3-97E9-24F6969899D6Q52865652-FCD9F661-F7FF-403E-8403-4E595A7222B0Q53922343-1A576C17-42C1-41A6-89A2-37803F993C66Q56517416-4CDEBDA3-2FE6-4A40-A47C-B9966F97FFCBQ56888890-B29E1154-052F-47D5-9CCE-29721476D157Q57024017-03F67C87-C76A-4B62-AAE2-D16D27CB9F69Q57283502-ED25B0F6-D11A-459A-A803-9A1FF958E713Q57314037-9440FA86-C5BE-4238-8152-9FE4C84D8E69Q57314038-DCAAA501-A9D0-4007-B1B3-D321557E57D9Q57611681-23CC1038-D80A-440F-A3DD-4DF22F9BB428Q57823933-764DA7DB-BFF7-4557-8D56-76A2A0FD83B1Q60017787-E5B2FBD2-E0A2-4B63-AF39-6658BB157B9DQ64044160-48AC7B32-595C-4810-B533-BE89772D9A20Q64276630-551E064F-F75D-49E6-B0D3-047A11C0338BQ85635857-0D2C5F5D-B385-46D0-A2C6-203676DF30F2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joe-Elie Salem
@ast
Joe-Elie Salem
@en
Joe-Elie Salem
@es
Joe-Elie Salem
@sl
type
label
Joe-Elie Salem
@ast
Joe-Elie Salem
@en
Joe-Elie Salem
@es
Joe-Elie Salem
@sl
prefLabel
Joe-Elie Salem
@ast
Joe-Elie Salem
@en
Joe-Elie Salem
@es
Joe-Elie Salem
@sl
P106
P21
P31
P496
0000-0002-0331-3307